These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8154521)

  • 21. Lack of hypotension with lovastatin and pravastatin.
    Kostis JB; Wilson AC
    Lancet; 1991 Nov; 338(8778):1339. PubMed ID: 1682723
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

  • 23. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil.
    Knoll RW; Ciafone R; Galen M
    Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin ulcers and myopathy associated with pravastatin therapy.
    Fernández-Torres R; del Pozo J; Almagro M; Yebra-Pimentel MT; Fernández-Jorge B; Mazaira M; Fonseca E
    Clin Exp Dermatol; 2009 Oct; 34(7):e237-8. PubMed ID: 19323663
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma mevalonate response in lovastatin-related myopathy.
    Maher VM; Pappu A; Illingworth DR; Thompson GR
    Lancet; 1989 Nov; 2(8671):1098. PubMed ID: 2572817
    [No Abstract]   [Full Text] [Related]  

  • 26. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia.
    Wiklund O; Angelin B; Bergman M; Berglund L; Bondjers G; Carlsson A; Lindén T; Miettinen T; Odman B; Olofsson SO
    Am J Med; 1993 Jan; 94(1):13-20. PubMed ID: 8420296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.
    Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; MacDonald JS
    Eur Heart J; 1992 Jul; 13 Suppl B():2-6. PubMed ID: 1644096
    [No Abstract]   [Full Text] [Related]  

  • 28. Extended clinical safety profile of lovastatin.
    Mantell G; Burke MT; Staggers J
    Am J Cardiol; 1990 Sep; 66(8):11B-15B. PubMed ID: 2206031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia.
    Nakai A; Nishikata M; Uchida T; Ichikawa M; Matsuyama K
    Biol Pharm Bull; 1997 Jan; 20(1):104-6. PubMed ID: 9013820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated exacerbation of myasthenia gravis.
    Cartwright MS; Jeffery DR; Nuss GR; Donofrio PD
    Neurology; 2004 Dec; 63(11):2188. PubMed ID: 15596782
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the effects of pravastatin and lovastatin on sleep disturbance in hypercholesterolemic subjects.
    Ehrenberg BL; Lamon-Fava S; Corbett KE; McNamara JR; Dallal GE; Schaefer EJ
    Sleep; 1999 Feb; 22(1):117-21. PubMed ID: 9989373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis.
    Goldman JA; Fishman AB; Lee JE; Johnson RJ
    Arthritis Rheum; 1989 Mar; 32(3):358-9. PubMed ID: 2930608
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of lovastatin and pravastatin on sleep efficiency and sleep stages.
    Vgontzas AN; Kales A; Bixler EO; Manfredi RL; Tyson KL
    Clin Pharmacol Ther; 1991 Dec; 50(6):730-7. PubMed ID: 1752118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lovastatin-induced acute rhabdomyolysis.
    Kogan AD; Orenstein S
    Postgrad Med J; 1990 Apr; 66(774):294-6. PubMed ID: 2385552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM.
    Garg A; Grundy SM
    Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myxoedema revealed by simvastatin induced myopathy.
    al-Jubouri MA; Briston PG; Sinclair D; Chinn RH; Young RM
    BMJ; 1994 Feb; 308(6928):588. PubMed ID: 8148686
    [No Abstract]   [Full Text] [Related]  

  • 39. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.